198 related articles for article (PubMed ID: 22438973)
41. Patterns of gene promoter methylation in squamous cell cancer of the head and neck.
Hasegawa M; Nelson HH; Peters E; Ringstrom E; Posner M; Kelsey KT
Oncogene; 2002 Jun; 21(27):4231-6. PubMed ID: 12082610
[TBL] [Abstract][Full Text] [Related]
42. Prognostic value of aberrant promoter hypermethylation of tumor-related genes in early-stage head and neck cancer.
Misawa K; Mochizuki D; Imai A; Endo S; Mima M; Misawa Y; Kanazawa T; Carey TE; Mineta H
Oncotarget; 2016 May; 7(18):26087-98. PubMed ID: 27027429
[TBL] [Abstract][Full Text] [Related]
43. Aberrant promoter hypermethylation of multiple genes in head and neck squamous cell carcinoma.
Puri SK; Si L; Fan CY; Hanna E
Am J Otolaryngol; 2005; 26(1):12-7. PubMed ID: 15635575
[TBL] [Abstract][Full Text] [Related]
44. Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix.
Dong SM; Kim HS; Rha SH; Sidransky D
Clin Cancer Res; 2001 Jul; 7(7):1982-6. PubMed ID: 11448914
[TBL] [Abstract][Full Text] [Related]
45. Influence of MTHFR Genetic Background on p16 and MGMT Methylation in Oral Squamous Cell Cancer.
Ferlazzo N; Currò M; Zinellu A; Caccamo D; Isola G; Ventura V; Carru C; Matarese G; Ientile R
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28353639
[TBL] [Abstract][Full Text] [Related]
46. p16(INK4A) promoter hypermethylation is associated with invasiveness and prognosis of oral squamous cell carcinoma in an age-dependent manner.
Su PF; Huang WL; Wu HT; Wu CH; Liu TY; Kao SY
Oral Oncol; 2010 Oct; 46(10):734-9. PubMed ID: 20729138
[TBL] [Abstract][Full Text] [Related]
47. Promotor hypermethylated genes: Prospective diagnostic biomarkers in oral cancerogenesis.
Dvojakovska S; Popovic-Monevska D; Grcev A; Pancevski G; Benedetti A; Popovski V; Dimovski A; Stamatoski A
J Craniomaxillofac Surg; 2018 Oct; 46(10):1737-1740. PubMed ID: 30100382
[TBL] [Abstract][Full Text] [Related]
48. Promoter Hypermethylation Profiling Identifies Subtypes of Head and Neck Cancer with Distinct Viral, Environmental, Genetic and Survival Characteristics.
Choudhury JH; Ghosh SK
PLoS One; 2015; 10(6):e0129808. PubMed ID: 26098903
[TBL] [Abstract][Full Text] [Related]
49. An inverse correlation between Interleukin-6 and select gene promoter methylation in patients with gastric cancer.
Tang LP; Cho CH; Hui WM; Huang C; Chu KM; Xia HH; Lam SK; Rashid A; Wong BC; Chan AO
Digestion; 2006; 74(2):85-90. PubMed ID: 17139167
[TBL] [Abstract][Full Text] [Related]
50. Promoter region hypermethylation and mRNA expression of MGMT and p16 genes in tissue and blood samples of human premalignant oral lesions and oral squamous cell carcinoma.
Bhatia V; Goel MM; Makker A; Tewari S; Yadu A; Shilpi P; Kumar S; Agarwal SP; Goel SK
Biomed Res Int; 2014; 2014():248419. PubMed ID: 24991542
[TBL] [Abstract][Full Text] [Related]
51. Validation of nucleolar protein 4 as a novel methylated tumor suppressor gene in head and neck cancer.
Demokan S; Chuang AY; Pattani KM; Sidransky D; Koch W; Califano JA
Oncol Rep; 2014 Feb; 31(2):1014-20. PubMed ID: 24337411
[TBL] [Abstract][Full Text] [Related]
52. KRAS, BRAF oncogene mutations and tissue specific promoter hypermethylation of tumor suppressor SFRP2, DAPK1, MGMT, HIC1 and p16 genes in colorectal cancer patients.
Bagci B; Sari M; Karadayi K; Turan M; Ozdemir O; Bagci G
Cancer Biomark; 2016 Jun; 17(2):133-43. PubMed ID: 27540971
[TBL] [Abstract][Full Text] [Related]
53. Association between hypermethylated tumor and paired surgical margins in head and neck squamous cell carcinomas.
Martone T; Gillio-Tos A; De Marco L; Fiano V; Maule M; Cavalot A; Garzaro M; Merletti F; Cortesina G
Clin Cancer Res; 2007 Sep; 13(17):5089-94. PubMed ID: 17785562
[TBL] [Abstract][Full Text] [Related]
54. Aberrant promoter hypermethylation in serum DNA from patients with silicosis.
Umemura S; Fujimoto N; Hiraki A; Gemba K; Takigawa N; Fujiwara K; Fujii M; Umemura H; Satoh M; Tabata M; Ueoka H; Kiura K; Kishimoto T; Tanimoto M
Carcinogenesis; 2008 Sep; 29(9):1845-9. PubMed ID: 18632757
[TBL] [Abstract][Full Text] [Related]
55. Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism and folate intake in esophageal squamous cell carcinoma.
Chen J; Huang ZJ; Duan YQ; Xiao XR; Jiang JQ; Zhang R
Asian Pac J Cancer Prev; 2012; 13(10):5303-6. PubMed ID: 23244153
[TBL] [Abstract][Full Text] [Related]
56. Aberrant DNA methylation of P16, MGMT, hMLH1 and hMSH2 genes in combination with the MTHFR C677T genetic polymorphism in gastric cancer.
Xiong HL; Liu XQ; Sun AH; He Y; Li J; Xia Y
Asian Pac J Cancer Prev; 2013; 14(5):3139-42. PubMed ID: 23803092
[TBL] [Abstract][Full Text] [Related]
57. Analysis of promoter hypermethylation of death-associated protein kinase and p16 tumor suppressor genes in actinic keratoses and squamous cell carcinomas of the skin.
Tyler LN; Ai L; Zuo C; Fan CY; Smoller BR
Mod Pathol; 2003 Jul; 16(7):660-4. PubMed ID: 12861061
[TBL] [Abstract][Full Text] [Related]
58. Epigenetic modulation of BRCA-1 and MGMT genes, and histones H4 and H3 are associated with breast tumors.
Paydar P; Asadikaram G; Nejad HZ; Akbari H; Abolhassani M; Moazed V; Nematollahi MH; Ebrahimi G; Fallah H
J Cell Biochem; 2019 Aug; 120(8):13726-13736. PubMed ID: 30938887
[TBL] [Abstract][Full Text] [Related]
59. [Promoter methylation of DAPK1, RAR-β and MGMT in exfoliated cervical cytology and its clinical application].
Zhong ZJ; Yang JX; Cao DY; Sun Y; Sun LL; Cheng XM; Chen J; Lang JH; Shen K
Zhonghua Fu Chan Ke Za Zhi; 2012 Mar; 47(3):196-200. PubMed ID: 22781071
[TBL] [Abstract][Full Text] [Related]
60. Promoter hypermethylation of death-associated protein kinase and p16 genes in vulvar lichen sclerosus.
Aidé S; Lattario FR; Almeida G; do Val IC; Carvalho Mda G
J Low Genit Tract Dis; 2012 Apr; 16(2):133-9. PubMed ID: 22371043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]